Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan.
Departments of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, Yufu, Japan.
Obes Surg. 2022 Sep;32(9):2994-3004. doi: 10.1007/s11695-022-06182-x. Epub 2022 Jun 30.
On November 25, 2021, the IFSO-Asia-Pacific Chapter (IFSO-APC) Virtual Meeting 2021 was held online, and the representatives from the Asia-Pacific region presented 10 years of change in bariatric/metabolic surgery and the influence of COVID-19 in the special session of "IFSO-APC National Reports 2010-2020". We herein report the summarized data.
National bariatric/metabolic surgery data, which included the data of 2010 and 2020, were collected from the representatives using a questionnaire that consisted of 10 general questions. At the congress, the data were calculated and summarized.
Thirteen of the 14 national societies responded to the survey. From 2010 to recent years, the populations of individuals with obesity (BMI ≥ 30 kg/m) and individuals with diabetes both significantly increased. Eight countries and regions expanded the lower limit of criteria for bariatric surgery by 2-5 kg/m (BMI), and 5 countries newly established criteria for metabolic surgery in the last ten years. Sixty-nine percent of the countries currently run public health insurance systems, which doubled from 2010. The number of bariatric surgeons and institutions increased more than threefold from 2010. In 2010, 2019, and 2020, surgeons in IFSO-APC societies performed 18,280, 66,010, and 49,553 bariatric/metabolic surgeries, respectively. Due to the COVID pandemic, restriction policies significantly reduced access to surgery in South and Southeast Asian countries. The biggest changes included increased numbers of bariatric surgeons and institutions, operation numbers, public insurance coverage, raising awareness, and national registry systems.
For the last 10 years, bariatric/metabolic surgery has rapidly grown in the Asia-Pacific region.
2021 年 11 月 25 日,IFSO-Asia-Pacific 分会(IFSO-APC)虚拟会议 2021 在线上举行,亚太地区的代表在“IFSO-APC 2010-2020 年国家报告”专场会议上展示了减重代谢手术 10 年来的变化和 COVID-19 的影响。现将汇总数据报告如下。
使用包含 10 个一般问题的问卷,由代表收集各国 2010 年和 2020 年的减重代谢手术数据。在大会上,对数据进行计算和汇总。
14 个国家协会中的 13 个对调查做出了回应。从 2010 年到近年,肥胖人群(BMI≥30kg/m)和糖尿病患者人群均显著增加。8 个国家和地区将减重手术的标准下限扩大了 2-5kg/m(BMI),5 个国家在过去 10 年中建立了代谢手术的新标准。目前 69%的国家实行公共健康保险制度,比 2010 年增加了一倍。2010 年至 2020 年,减重外科医生和机构的数量增加了两倍多。2010 年、2019 年和 2020 年,IFSO-APC 学会的外科医生分别完成了 18280、66010 和 49553 例减重/代谢手术。由于 COVID 大流行,限制政策极大地减少了南亚和东南亚国家获得手术的机会。最大的变化包括增加了减重外科医生和机构的数量、手术数量、公共保险覆盖范围、提高认识和国家登记系统。
在过去的 10 年中,亚太地区的减重代谢手术迅速发展。